Press release
Colon Cancer Market Projected to Garner Significant Revenues by 2021
Get access to full summary @: http://www.persistencemarketresearch.com/market-research/colon-cancer-market.asp
Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation. The American Society of Clinical Oncology (ASCO) recommends patients affected with colon cancer, for testing of genetic mutation in the KRAS gene which accounts for about 30% to 40% of colon tumors.
There are three primary recommended therapies for treating colon cancer – surgery, chemotherapy and radiation. Surgical procedures such as colonoscopy, endoscopic mucosal resection, colectomy and laparoscopy are preferred in early-stage and invasive colon cancer treatment therapy. Besides, chemotherapy involves administration of drugs that destroy cancer cells, usually recommended after the surgery to reduce the risk of recurrence.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/5423
In addition, targeted drugs such as bevacizumab (Avastin), cetuximab (Erbitux), panitumumab (Vectibix) and regorafenib (Stivarga) are administered to patients with advanced colon cancer. Radiation therapy utilizes powerful X-ray radiations to kill the cancer cells left after surgery, shrink large tumors before the surgery or relieve symptoms of colon cancer. Usually combined with chemotherapy, radiation therapy aids in reducing the risk of recurrence.
According to the Colon Cancer Alliance, colon cancer is the third most commonly diagnosed and second leading cause of cancer in the U.S. Rising incidences of colon cancer and high pricing of products have attracted pharmaceutical companies to develop and market new products. Healthcare practitioners are now cautioned with the cost-benefit ratio of colon cancer drugs owing to large presence and high pricing of products in this market. Extensive research and development in this field is expected to provide better and more effective medications in the future.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/5423
Some of the key players contributing to this market include Bedford Laboratories, Sanofi Aventis, Bayer AG, GlaxoSmithKline plc and Teva Pharmaceutical Industries Ltd.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colon Cancer Market Projected to Garner Significant Revenues by 2021 here
News-ID: 592031 • Views: …
More Releases from Persistence Market Research
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market
The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and…
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts.
Forged automotive components are critical to…
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the…
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring…
More Releases for Colon
Colon Broom Real Reviews - Does Colon Broom Work for Weight Loss?
Colon Broom is a regular fiber-based supplement that promotes healthy digestion and gut health by utilizing natural components. The product is aimed at people who are tired of slow digestion, bloating, and irregularity. However, rather than a harsh cleanse or a fast detox, this product takes a gentler, more sustainable approach: fiber.
The ingredients of Colon Broom are basic but effective, with psyllium husk being the star. …
Colon Cleansing Supplements Market Overview 2022 to 2030, Future Trends and Fore …
Colon Cleansing Supplements Market 2022 Global Industry research report provide detailed analysis of growth factors of the global industry as well as it gives analysis of market share, latest trends, size and forecast until 2030. The Colon Cleansing Supplements industry report has studied key opportunities in the market and influencing factor which is useful to the business.
The global Colon Cleansing Supplements market is expected to register a CAGR of 3.2%…
Global Colon Cleanse Market Analysis (2020-2025)
Global Info Research offers a latest published report on Colon Cleanse Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Colon Cleanse Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/266412/colon-cleanse
Market…
Global Colon Cleansing Supplements Market: Key Players to Tap Emerging Markets i …
LOS ANGELES, United States: QY Research as of late produced a research report titled, “Global Colon Cleansing Supplements Market Research Report 2020". The research report speak about the potential development openings that exist in the worldwide market. The report is broken down on the basis of research procedures procured from historical and forecast information. The global Colon Cleansing Supplements market is relied upon to develop generously and flourish as far…
Colon Cleansing Supplements Market- Key Vendors ( Vita Balance, PRIVATELABELSUPP …
Global Colon Cleansing Supplements Market: Snapshot
Colon cleansing is essential if one needs to lose a few pounds of weight, solve acne problems, or improve their digestive system. There are several supplements are now available that adequately match the requirements and according to the findings of this study, the demand for them would be expanding profitably over the course of 2017 to 2027, gaining traction from increased awareness levels among the…
Colon Cancer Pipeline Therapeutics Review H1 2017
Colon Cancer Pipeline Drugs Review H1 2017 provides an overview of the Colon Cancer therapeutics (Oncology) pipeline landscape. Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer.
For More on Colon Cancer Pipeline Review H1 2017 Report Inquire @ https://tinyurl.com/Colon-Cancer-Therapeutic .
Report Description:
Pharmaceutical guide Colon Cancer - Pipeline…
